美国

我们是谁

  • 1 月 9, 2024
    Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types
  • 1 月 9, 2024
    ERASur研究：测试在有限转移性结直肠癌的常规系统疗法基础上增加全烧蚀疗法的效果
  • 1 月 8, 2024
    TAS-102 加放射疗法治疗结直肠癌肝转移患者肝脏的研究
  • 1 月 8, 2024
    M9241 与肝动脉输注泵 (HAIP) 和全身疗法联合用于转移性结直肠癌或肝内胆管癌患者的治疗
  • 1 月 8, 2024
    评估自体钙粘蛋白 17 嵌合抗原受体 (CAR) T 细胞疗法 CHM-2101 的 1/2 期研究
  • 1 月 8, 2024
    RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC
  • 1 月 5, 2024
    Study of TU2218 in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
  • 1 月 5, 2024
    Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation
  • 12 月 18, 2023
    Immunotherapy for Third Line Metastatic Colorectal Cancer
  • 11 月 13, 2023
    Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)